Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
What would a new Fed chair do if inflation stayed stubborn while growth slowed? This article imagines Chair Kevin War...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
Investors are testing a new approach to fund life’s milestones—without tapping the core retirement nest egg. The cele...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...
A bold investing idea sits beyond Nvidia: a mid-sized AI semiconductor stock poised to outrun the market over the nex...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
A 67-year-old retiree can add roughly $50,000 a year from self-employment without reducing Social Security benefits, ...
With the trust fund projected to deplete in the coming years, benefit payments could fall short unless Congress acts....